Bio-Gene Technology (ASX:BGT) Beginning Cash Position: A$1.14 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Bio-Gene Technology Beginning Cash Position?

Bio-Gene Technology ASX:BGT Beginning Cash Position is A$1.14 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Bio-Gene Technology's Beginning Cash Position for the quarter that ended in Dec. 2025 was A$1.14 Mil.

Bio-Gene Technology's quarterly Beginning Cash Position increased from Dec. 2024 (A$2.21 Mil) to Jun. 2025 (A$2.81 Mil) but then declined from Jun. 2025 (A$2.81 Mil) to Dec. 2025 (A$1.14 Mil).

Bio-Gene Technology's annual Beginning Cash Position declined from Jun. 2023 (A$6.34 Mil) to Jun. 2024 (A$2.99 Mil) and declined from Jun. 2024 (A$2.99 Mil) to Jun. 2025 (A$2.21 Mil).

Bio-Gene Technology Beginning Cash Position Related Terms

Bio-Gene Technology Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Bio-Gene Technology's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gene Technology Beginning Cash Position Chart

Bio-Gene Technology Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
Get a 7-Day Free Trial 5.52 3.93 6.34 2.99 2.21

Bio-Gene Technology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.99 3.23 2.21 2.81 1.14

Bio-Gene Technology Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of A$1.14 Mil mean?
Bio-Gene Technology (ASX:BGT) has a Beginning Cash Position of A$1.14 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Bio-Gene Technology and its competitors.
Is Bio-Gene Technology's Beginning Cash Position too high?
Bio-Gene Technology's current Beginning Cash Position is A$1.14 Mil.
How does Bio-Gene Technology's Beginning Cash Position compare to VRTX and REGN?
Bio-Gene Technology's Beginning Cash Position of A$1.14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Bio-Gene Technology and its competitors. Bio-Gene Technology's current Beginning Cash Position is A$1.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gene Technology stock overvalued right now?
Bio-Gene Technology (ASX:BGT) has a current Beginning Cash Position of A$1.14 Mil. The current Beginning Cash Position is A$1.14 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Bio-Gene Technology (ASX:BGT), the current Beginning Cash Position is A$1.14 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Gene Technology Business Description

Address 400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance and toxicity. Its products are based on a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. Bio-Gene's products have multiple applications across public health, crop protection, grain storage, and consumer use. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.